IP Library Granted Patent US 11,253,631
Granted Patent B2
US 11,253,631 · App. 15/767,957 · Granted Feb 22, 2022

Soft tissue protein compositions, methods of making, and uses thereof

Inventors: Amit Prakash Govil (Carlsbad, CA); Bryan Choi (Carlsbad, CA); Sahil Jalota (Carlsbad, CA)
Assignee: Biologies Technologies
A61L27/3687A23J1/02A23J1/04A61L27/3604A61L27/44A61L2430/34A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,253,631
App. No.
15/767,957
Granted
Feb 22, 2022
Kind
B2
Abstract

Provided herein are soluble soft tissue protein compositions that can contain one or more soft-tissue bioactive factors, methods of making the soluble soft tissue protein compositions, and methods of using the soluble soft tissue protein compositions.

Claims (21)

1. A method of making a soluble soft tissue protein composition, the method comprising:

harvesting soft tissue from a donor to obtain harvested soft tissue, where the soft tissue contains soft tissue cells;

heating the harvested soft tissue to at least 20° C.;

lysing the soft tissue cells by osmotic shock without a detergent to obtain a soft tissue cell lysate;

isolating the soft tissue lysate from the soft tissue to yield the soluble soft tissue protein composition; and

dehydrating the soluble soft tissue lysate to obtain a dehydrated soluble soft tissue protein composition.

2. The method of claim 1 , further comprising the step of fractionating the soft tissue cell lysate via centrifugation to obtain a soluble soft tissue protein fraction after lysing the soft tissue cells.

3. The method of claim 1 , wherein heating the harvested soft tissue occurs at about 20° C. to about 40° C.

4. The method of claim 1 , further comprising the step of washing the harvested soft tissue.

5. The method of claim 4 , wherein the steps of washing the harvested soft tissue, heating the harvested soft tissue, and lysing soft tissue cells occur simultaneously.

6. The method of claim 1 , further comprising the step of adding a stabilization solution prior to dehydrating.

7. The method of claim 6 , wherein an amount of the dehydrated soluble soft tissue protein composition in stabilization solution is implanted in or otherwise administered to a subject in need thereof.

8. The method of claim 6 , further comprising the step of applying an amount of the dehydrated soluble soft tissue protein composition in stabilization solution to a scaffold.

9. The method of claim 8 , wherein the scaffold is implanted in or otherwise administered to a subject in need thereof.

10. The method of claim 1 , further comprising the step of filtering the soluble soft tissue protein fraction.

11. The method of claim 1 , further comprising the step of selectively filtering or isolating the soft tissue cells to obtain a desired cell population prior to lysing the soft tissue cells.

12. The method of claim 11 , wherein the step of lysing further comprises lysing the desired cell population.

13. The method of claim 11 , wherein the desired cell population is adipocytes.

14. The method of claim 1 , wherein an amount of the dehydrated soluble soft tissue protein composition is implanted in or otherwise administered to a subject in need thereof.

15. The method of claim 1 , further comprising the step of applying an amount of the dehydrated soluble soft tissue protein composition to a scaffold.

16. The method of claim 15 , wherein the scaffold is implanted in or otherwise administered to a subject in need thereof.

Assignments (7)
SECURITY INTEREST Recorded Sep 18, 2025
From: ISTO TECHNOLOGIES II, LLC; ADVANCED BIOLOGICS LLC,; ARTERIOCYTE MEDICAL SYSTEMS, INC.; THERACELL, LLC
To: GOLUB CAPITAL MARKETS LLC
Reel/Frame 072300/0216 →
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2025
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
Reel/Frame 072274/0408 →
SECURITY INTEREST Recorded Oct 18, 2023
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065271/0059 →
RELEASE OF SECURITY INTEREST Recorded Aug 21, 2023
From: YEUNG, CHRISTOPHER A; SKW PARTNERS LP; SPINALGENICS, LLC; ROH, JEFFREY
To: ADVANCED BIOLOGICS LLC; GOVIL, AMIT
Reel/Frame 064650/0380 →
SECURITY INTEREST Recorded Oct 18, 2021
From: GOVIL, AMIT; ADVANCED BIOLOGICS LLC
To: YEUNG, CHRISTOPHER A.; SKW PARTNERS LP; SPINALGENICS, LLC; ROH, JEFFREY
Reel/Frame 057815/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2020
From: BIOLOGICA TECHNOLOGIES
To: ADVANCED BIOLOGICS, LLC
Reel/Frame 051562/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2018
From: GOVIL, AMIT PRAKASH; CHOI, BRYAN; JALOTA, SAHIL
To: BIOLOGICA TECHNOLOGIES
Reel/Frame 047551/0046 →